US equities
|
NVDA
$237.09
▲+1.34%
SPCX
$165.45
▲+4.08%
MU
$1,059.04
▼-1.47%
TSLA
$376.12
▲+1.49%
MSFT
$527.13
▲+1.85%
INTC
$116.22
▼-2.60%
SNDK
$1,717.00
▼-0.17%
AMD
$627.90
▼-0.95%
NVDA
$237.09
▲+1.34%
SPCX
$165.45
▲+4.08%
MU
$1,059.04
▼-1.47%
TSLA
$376.12
▲+1.49%
MSFT
$527.13
▲+1.85%
INTC
$116.22
▼-2.60%
SNDK
$1,717.00
▼-0.17%
AMD
$627.90
▼-0.95%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Glaukos Corporation Common Stock
(NY:
GKOS
)
164.19
+0.44 (+0.27%)
Delayed Quote
Updated: 10:02 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Glaukos Corporation Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Wells Fargo Downgrades Glaukos To Sell On iStent Reimbursement Cuts
↗
July 20, 2021
Wells Fargo analyst Lawrence Biegelsen downgraded Glaukos to Underweight from Equal Weight with a price target of $41, down from $100.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021
↗
July 20, 2021
Upgrades For Bank of Marin Bancorp (NASDAQ:
Via
Benzinga
Glaukos Corporation to Release Second Quarter 2021 Financial Results after Market Close on August 5
July 15, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos plunges after CMS suggests slashing iStent reimbursement
↗
July 14, 2021
William Blair downgraded Glaukos following the
Via
Talk Markets
Glaukos's Earnings: A Preview
↗
May 04, 2021
Glaukos (NYSE:GKOS) announces its next round of earnings this Wednesday, May 05. Here is Benzinga's look at Glaukos's Q1 earnings report. Net Income, Earnings, And Earnings Per...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
↗
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
55 Biggest Movers From Yesterday
↗
July 15, 2021
Gainers SGOCO Group, Ltd. (NASDAQ: SGOC) shares gained 37.6% to settle at $13.20 on Wednesday. SGOCO Group regained compliance with Nasdaq's listing standards on July 12 by...
Via
Benzinga
Mid-Afternoon Market Update: Dow Gains 50 Points; Imara Shares Plunge
↗
July 14, 2021
Toward the end of trading Wednesday, the Dow traded up 0.15% to 34,942.77 while the NASDAQ rose 0.07% to 14,687.21. The S&P also rose, gaining 0.26% to 4,380.58. The U.S. has...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 14, 2021
Gainers AcelRx Pharmaceuticals (NASDAQ:ACRX
Via
Benzinga
Mid-Day Market Update: Aspen Group Drops Following Q4 Results; Datasea Shares Surge
↗
July 14, 2021
Midway through trading Wednesday, the Dow traded up 0.05% to 34,907.35 while the NASDAQ rose 0.48% to 14,747.61. The S&P also rose, gaining 0.24% to 4,379.85. The U.S. has the...
Via
Benzinga
Topics
Stocks
34 Stocks Moving In Wednesday's Mid-Day Session
↗
July 14, 2021
Gainers Datasea Inc. (NASDAQ: DTSS) climbed 85% to $5.42. Datasea’s subsidiary Shuhai Zhangxun Information Technology Co., Ltd inked six purchase and distribution...
Via
Benzinga
Why Glaukos Stock Is Tanking Today
↗
July 14, 2021
Proposed rates from CMS for fiscal 2022 weren't what investors expected.
Via
The Motley Fool
Mid-Morning Market Update: Markets Open Higher; Citigroup Earnings Beat Expectations
↗
July 14, 2021
Following the market opening Wednesday, the Dow traded up 0.26% to 34,979.05 while the NASDAQ rose 0.40% to 14,736.66. The S&P also rose, gaining 0.30% to 4,382.38. The U.S....
Via
Benzinga
Topics
Earnings
Stocks
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021
↗
July 14, 2021
Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 14, 2021
Gainers Qualigen Therapeutics (NASDAQ:QLGN) stock moved upwards by 8.98% to $1.94 during Wednesday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
William Blair Downgrades Glaukos After Disappointing CMS Rate; Shares Drop
↗
July 14, 2021
Centers for Medicare and Medicaid Services (CMS) issued its fiscal 2022 proposed physician fee schedule, which included two combined Category I cataract plus stent procedure...
Via
Benzinga
Glaukos Comments on the Centers for Medicare and Medicaid Services 2022 Proposed Physician Fee Schedule
July 14, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Stock Sees Its Relative Strength Rating Improve To Key Above-80 Level
↗
July 01, 2021
Glaukos stock had its Relative Strength (RS) Rating upgraded from 78 to 81 Thursday. Is Glaukos on your watchlist?
Via
Investor's Business Daily
Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. NDA Phase 3 Clinical Trials for iDose® TR
June 10, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Australia’s TGA Regulatory Approval for PRESERFLO™ MicroShunt
June 08, 2021
From
Glaukos
Via
Business Wire
Glaukos Announces Participation in the William Blair 41st Annual Growth Stock Conference
May 19, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Expands its PRESERFLO™ MicroShunt Relationship with Santen via New License Agreement
May 18, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Corp (GKOS) Q1 2021 Earnings Call Transcript
↗
May 05, 2021
GKOS earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Glaukos Corporation Announces First Quarter 2021 Financial Results
May 05, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces the Release of its 2020 Sustainability Report
April 27, 2021
From
Glaukos Corporation
Via
Business Wire
Glaukos Announces Global Licensing Agreement Amendment with Intratus, Inc. to Include the Treatment of Presbyopia
April 22, 2021
From
Glaukos Corporation
Via
Business Wire
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
↗
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
↗
April 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...
Via
Benzinga
Glaukos Corporation to Release First Quarter 2021 Financial Results after Market Close on May 5
April 14, 2021
From
Glaukos Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 8, 2021
↗
April 08, 2021
Upgrades According to Oppenheimer, the prior rating for Glaukos Corp (NYSE:GKOS) was changed from Perform to Outperform. Glaukos earned $0.02 in the fourth quarter,...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
